Why Teladoc Health Fell by 6.6% Today
Shares of Teladoc Health (NYSE: TDOC) were a bit sickly on Monday after one of the more prominent analysts tracking the stock knocked his target price down.
Truist Securities' Sandy Draper, who has closely followed the fortunes of Teladoc throughout the coronavirus pandemic, was the prognosticator shaving his price target. He now believes the company is worth $206 per share, quite some distance down from his previous level of $275. However, Draper still recommends Teladoc as a buy.
Image source: Getty Images.
Source Fool.com


